To Get Help Now
Click Here
 
Today's Date:

Pfizer Appeal Denied In $58 Million Prempro Award

AddThis Social Bookmark Button

The Nevada Supreme Court has denied Pfizer’s appeal of a $58 million award to Arlene Rowatt, Jeraldine Scofield and Pamela Forrester who developed breast cancer after using Prempro and Premarin and accused Pfizer’s Wyeth division of hiding the association between Prempro and Premarin and breast cancer.

Bloomberg reports that Wyeth saw annual sales of more than $2 billion for their hormone replacement therapy drugs before a 2002 study revealed that women who used the therapies had an increased risk of developing breast cancer.  They also report that the award is “largest to be upheld on appeal in thousands of hormone-replacement drug suits.” The original award was for $134 million, but was later reduced to a little over $57 million. In 2008, lawyers for the women were awarded more than $1.6 million in fees and expenses.

Pfizer has settled about one third of the thousands of lawsuits filed against the drug maker for Prempro and Premarin side effects, and has set aside $772 million for the remaining claims.

Bloomberg reports that of the three plaintiffs, only Jeraldine Scofield remains. Rowatt and Forrester have died of “causes unrelated to the litigation.”

 

 

breakinglawsuitnews.com disclaimer: This article: Pfizer Appeal Denied In $58 Million Prempro Award was posted on Wednesday, June 22nd, 2011 at 7:26 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.